Thyroid Hormone Action in Muscle Atrophy

Skeletal muscle atrophy is a condition associated with various physiological and pathophysiological conditions, such as denervation, cachexia, and fasting. It is characterized by an altered protein turnover in which the rate of protein degradation exceeds the rate of protein synthesis, leading to su...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Angela De Stefano, Raffaele Ambrosio, Tommaso Porcelli, Gianfranco Orlandino, Domenico Salvatore, Cristina Luongo
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/c7c8c086f38c414facbf475426fd81e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c7c8c086f38c414facbf475426fd81e8
record_format dspace
spelling oai:doaj.org-article:c7c8c086f38c414facbf475426fd81e82021-11-25T18:20:30ZThyroid Hormone Action in Muscle Atrophy10.3390/metabo111107302218-1989https://doaj.org/article/c7c8c086f38c414facbf475426fd81e82021-10-01T00:00:00Zhttps://www.mdpi.com/2218-1989/11/11/730https://doaj.org/toc/2218-1989Skeletal muscle atrophy is a condition associated with various physiological and pathophysiological conditions, such as denervation, cachexia, and fasting. It is characterized by an altered protein turnover in which the rate of protein degradation exceeds the rate of protein synthesis, leading to substantial muscle mass loss and weakness. Muscle protein breakdown reflects the activation of multiple proteolytic mechanisms, including lysosomal degradation, apoptosis, and ubiquitin–proteasome. Thyroid hormone (TH) plays a key role in these conditions. Indeed, skeletal muscle is among the principal TH target tissue, where TH regulates proliferation, metabolism, differentiation, homeostasis, and growth. In physiological conditions, TH stimulates both protein synthesis and degradation, and an alteration in TH levels is often responsible for a specific myopathy. Intracellular TH concentrations are modulated in skeletal muscle by a family of enzymes named deiodinases; in particular, in muscle, deiodinases type 2 (D2) and type 3 (D3) are both present. D2 activates the prohormone T4 into the active form triiodothyronine (T3), whereas D3 inactivates both T4 and T3 by the removal of an inner ring iodine. Here we will review the present knowledge of TH action in skeletal muscle atrophy, in particular, on the molecular mechanisms presiding over the control of intracellular T3 concentration in wasting muscle conditions. Finally, we will discuss the possibility of exploiting the modulation of deiodinases as a possible therapeutic approach to treat muscle atrophy.Maria Angela De StefanoRaffaele AmbrosioTommaso PorcelliGianfranco OrlandinoDomenico SalvatoreCristina LuongoMDPI AGarticlethyroid hormonedeiodinasemuscle atrophyMicrobiologyQR1-502ENMetabolites, Vol 11, Iss 730, p 730 (2021)
institution DOAJ
collection DOAJ
language EN
topic thyroid hormone
deiodinase
muscle atrophy
Microbiology
QR1-502
spellingShingle thyroid hormone
deiodinase
muscle atrophy
Microbiology
QR1-502
Maria Angela De Stefano
Raffaele Ambrosio
Tommaso Porcelli
Gianfranco Orlandino
Domenico Salvatore
Cristina Luongo
Thyroid Hormone Action in Muscle Atrophy
description Skeletal muscle atrophy is a condition associated with various physiological and pathophysiological conditions, such as denervation, cachexia, and fasting. It is characterized by an altered protein turnover in which the rate of protein degradation exceeds the rate of protein synthesis, leading to substantial muscle mass loss and weakness. Muscle protein breakdown reflects the activation of multiple proteolytic mechanisms, including lysosomal degradation, apoptosis, and ubiquitin–proteasome. Thyroid hormone (TH) plays a key role in these conditions. Indeed, skeletal muscle is among the principal TH target tissue, where TH regulates proliferation, metabolism, differentiation, homeostasis, and growth. In physiological conditions, TH stimulates both protein synthesis and degradation, and an alteration in TH levels is often responsible for a specific myopathy. Intracellular TH concentrations are modulated in skeletal muscle by a family of enzymes named deiodinases; in particular, in muscle, deiodinases type 2 (D2) and type 3 (D3) are both present. D2 activates the prohormone T4 into the active form triiodothyronine (T3), whereas D3 inactivates both T4 and T3 by the removal of an inner ring iodine. Here we will review the present knowledge of TH action in skeletal muscle atrophy, in particular, on the molecular mechanisms presiding over the control of intracellular T3 concentration in wasting muscle conditions. Finally, we will discuss the possibility of exploiting the modulation of deiodinases as a possible therapeutic approach to treat muscle atrophy.
format article
author Maria Angela De Stefano
Raffaele Ambrosio
Tommaso Porcelli
Gianfranco Orlandino
Domenico Salvatore
Cristina Luongo
author_facet Maria Angela De Stefano
Raffaele Ambrosio
Tommaso Porcelli
Gianfranco Orlandino
Domenico Salvatore
Cristina Luongo
author_sort Maria Angela De Stefano
title Thyroid Hormone Action in Muscle Atrophy
title_short Thyroid Hormone Action in Muscle Atrophy
title_full Thyroid Hormone Action in Muscle Atrophy
title_fullStr Thyroid Hormone Action in Muscle Atrophy
title_full_unstemmed Thyroid Hormone Action in Muscle Atrophy
title_sort thyroid hormone action in muscle atrophy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/c7c8c086f38c414facbf475426fd81e8
work_keys_str_mv AT mariaangeladestefano thyroidhormoneactioninmuscleatrophy
AT raffaeleambrosio thyroidhormoneactioninmuscleatrophy
AT tommasoporcelli thyroidhormoneactioninmuscleatrophy
AT gianfrancoorlandino thyroidhormoneactioninmuscleatrophy
AT domenicosalvatore thyroidhormoneactioninmuscleatrophy
AT cristinaluongo thyroidhormoneactioninmuscleatrophy
_version_ 1718411345960894464